Exelixis Stock Price

0.00 (0.0%)
Upgrade to Real-Time
Afterhours (Closed)
Best deals to access real time data!
CHART Trader
Monthly Subscription
for only
Canadian Level 1 + USA
Monthly Subscription
for only
Small Cap Basic
Monthly Subscription
for only
VAT not included
Company Name Stock Ticker Symbol Market Type
Exelixis Inc EXEL NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
0.00 0.0% 21.90 20:00:00
Close Price Low Price High Price Open Price Previous Close
Bid Price Ask Price Spread News
21.66 22.32 0.66 - 1
Last Trade Time Type Quantity Stock Price Currency
- 0 $ 21.90 USD

Exelixis Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 6.77B 309.00M 273.25M $ 967.78M $ 242.52M 1.02 25.00
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - 0.00% - -

more financials information »

Exelixis News

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical EXEL Price Data

Period † Open High Low VWAP Avg. Daily Vol Change %
1 Week22.6022.9221.5421.982,259,063-0.70-3.1%
1 Month23.8025.119921.5423.251,791,254-1.90-7.98%
3 Months23.5127.494419.8423.421,958,821-1.61-6.85%
6 Months26.87227.9019.8424.062,362,646-4.97-18.5%
1 Year17.3727.9013.6720.812,973,3344.5326.08%
3 Years26.0132.2013.4221.233,155,780-4.11-15.8%
5 Years5.9432.503.5517.643,760,30915.96268.69%

Exelixis Description

Exelixis is a biopharmaceutical firm that discovers, develops, and commercializes treatments for cancer. Its lead molecule cabozantinib is indicated for the treatment of patients with metastatic medullary thyroid cancer (as Cometriq) and advanced renal cell carcinoma, or kidney cancer, and hepatocellular carcinoma, or liver cancer (as Cabometyx). Exelixis and partner Roche have also brought Cotellic to market for the treatment of melanoma.
Your Recent History
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20201027 07:24:29